Pew, Hospitals, Device Manufacturers Urge Support for UDI in Claims

Pew, Hospitals, Device Manufacturers Urge Support for UDI in Claims

The Pew Charitable Trusts and several health organizations, hospital systems, and medical device manufacturers sent a letter on May 17 to Scott Gottlieb, the commissioner of the Food and Drug Administration, and Seema Verma, the administrator of the Centers for Medicare & Medicaid Services, urging them to continue their agencies’ support for efforts to add unique device identifiers (UDIs) to insurance claim forms. Including this information would allow researchers and providers to better track the safety and performance of medical devices over time.

The letter noted the importance of these identifiers in improving patient safety and reducing costs, and highlighted bipartisan support for this policy. The X12, a key advisory committee responsible for maintaining insurance claim forms, recommended adding UDIs to the forms in February.

National Homeownership Month

Article

37 Researchers Working to Transform Biomedical Science

Quick View
Article

Biomedical researchers are on the front lines of scientific innovation. From responding to global pandemics to pioneering lifesaving cancer treatments, these researchers push past scientific boundaries to solve pressing health challenges. For nearly 40 years, The Pew Charitable Trusts has supported more than 1,000 early-career biomedical scientists committed to this discovery.

Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.